Van Naarden Jacob 4
4 · ELI LILLY & Co · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Van Naarden Jacob
EVP,Pres LLY Oncology&HdCorpBD
Transactions
- Exercise/Conversion
Common Stock
2024-02-01+3,618→ 15,463 total - Tax Payment
Common Stock
2024-02-01$645.61/sh−1,685$1,087,853→ 13,778 total - Exercise/Conversion
Restricted Stock Unit
2024-02-01−3,618→ 0 totalFrom: 2024-02-01Exp: 2024-02-01→ Common Stock (3,618 underlying)
Holdings
- 4,342(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.